- UroToday Home
- Recent Abstracts
- Urologic Oncology
Testicular Cancer
Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection.
September 12, 2024
Financial distress in testicular cancer survivors and its impact on cancer survivors´ quality of life in the German health care system.
September 11, 2024
Conventional versus high-dose salvage chemotherapy for relapsed testicular germ cell tumours.
September 11, 2024
Efficacy and Safety of Testosterone Replacement in Testicular Cancer Survivors With Treatment-Influenced Hypogonadism: A Systematic Review.
September 9, 2024
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis.
September 4, 2024
Evaluation and Management of Testicular Cancer After Late Relapse.
September 2, 2024
Understanding the role of endocrine disrupting chemicals in testicular germ cell cancer: Insights into molecular mechanisms.
September 2, 2024
Oncological treatments have limited effects on the fertility prognosis in testicular cancer: A systematic review and meta-analysis.
August 30, 2024
Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER Registries.
August 19, 2024
Cognitive function in long-term testicular cancer survivors: Impact of modifiable factors.
August 16, 2024
Testicular Germ Cell Tumours - features and prospects of the novel tumour marker microRNA-371a-3p (M371 test): a narrative review.
August 15, 2024
"Uncovering the unspoken": a narrative analysis of patients' experiences with testicular cancer.
August 14, 2024
Discriminating Malignant from Benign Testicular Masses Using Multiparametric Magnetic Resonance Imaging-A Prospective Single-Center Study.
August 12, 2024